DOLLAR TREE, INC.

DLTR

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 133,329Value: $16.4M

**Signal Note: Driehaus Biotech Pivot or Portfolio Rebalancing?** Driehaus Capital's $16.4M initiation in DLTR is noteworthy given the firm's stated biotech focus—this suggests either a significant tactical shift toward consumer discretionary/retail or a rotation out of higher-valuation biotech. The timing aligns with DLTR's Q3 2024 strength in discount retail amid consumer spending pressure, though this move lacks the specificity of typical biotech catalyst plays and warrants monitoring for whether it signals broader biotech position reduction.

More DLTR Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: